Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
DARA BIOSCIENCES
(NQ:
DARA
)
0.6701
USD
UNCHANGED
Official Closing Price
/ Updated:
3:59 PM EDT, Jun 19, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
0.7000
Bid (Size)
0.5577 (200)
Ask (Size)
0.7938 (3000)
Prev. Close
0.6701
Today's Range
0.6700 - 0.7000
52wk Range
0.6151 - 1.380
Shares Outstanding
25,000,961
Dividend Yield
N/A
Top News
More News
DARA BioSciences Grants T3D Therapeutics Exclusive Worldwide Rights to Develop and Commercialize DB959
June 18, 2013
Agreement Underpins DARA's Strategy to Focus on the Commercialization of Oncology Supportive Care Products
Read More
from
Marketwired News Releases
DARA Biosciences Enrolls Leading Oncology Centers in Breast Cancer Patient Registry
June 03, 2013
CAPTURE: Compliance and Preference for Tamoxifen Registry Focuses on Gaining Insights Into Aspects of Tamoxifen Therapy in Breast Cancer Patients
Read More
from
Marketwired News Releases
More News
Read More
DARA Reports First Quarter 2013 Financial Results and Operational Highlights
May 15, 2013
from
Marketwired News Releases
Helsinn, DARA Announce U.S. Launch of Gelclair
April 22, 2013
category
DARA
,
Benzinga
,
News
, and 1 more.
from
Latest Articles from Benzinga.com
DARA and HELSINN Announce U.S. Launch of Gelclair(R), an FDA-Cleared Oral Gel for the Treatment of Oral Mucositis
April 22, 2013
from
Marketwired News Releases
DARA BioSciences (DARA) Enters Distribution Agreement w/ Prime Therapeutics
April 03, 2013
from
StreetInsider.com News Articles
DARA BioSciences Enters Into Distribution Agreement for Gelclair(R) and Soltamox(R) With Prime Therapeutics Specialty Pharmacy
April 03, 2013
from
Marketwired News Releases
DARA Reports Year-End 2012 Financial Results
April 01, 2013
from
Marketwired News Releases
Biotech Industry Looks to Benefit From FDA's New "Breakthrough" Designation
March 20, 2013
from
Marketwired News Releases
DARA BioSciences to Present at 25th Annual ROTH Conference
March 18, 2013
from
Marketwired News Releases
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here